Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients
International Journal of Clinical Oncology, 07/17/2012
Clinical Article
Kita Y et al. – In multivariate analysis, hemoglobin and alkaline phosphatase were significant predictive factors for OS. A reduced–dose regimen of docetaxel has no inferior impact on overall survival (OS). =



